Pablo Cerezuela

531 total citations
27 papers, 303 citations indexed

About

Pablo Cerezuela is a scholar working on Oncology, Molecular Biology and Animal Science and Zoology. According to data from OpenAlex, Pablo Cerezuela has authored 27 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 8 papers in Molecular Biology and 5 papers in Animal Science and Zoology. Recurrent topics in Pablo Cerezuela's work include Melanoma and MAPK Pathways (7 papers), Cutaneous Melanoma Detection and Management (6 papers) and CAR-T cell therapy research (3 papers). Pablo Cerezuela is often cited by papers focused on Melanoma and MAPK Pathways (7 papers), Cutaneous Melanoma Detection and Management (6 papers) and CAR-T cell therapy research (3 papers). Pablo Cerezuela collaborates with scholars based in Spain, Ireland and United States. Pablo Cerezuela's co-authors include Salvador Martín‐Algarra, Alfonso Berrocal, María González‐Cao, Ainara Soria, Iván Márquez‐Rodas, A.M. Gutiérrez, J. M. Castro Cerón, Cándido Gutiérrez Panizo, J Mayans and A. Montes and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Pablo Cerezuela

23 papers receiving 295 citations

Peers

Pablo Cerezuela
Kathy L. Miller United States
Gail D. Stockman United States
G. Wood United States
Chakib Boussahmain United States
Paul L. Black United States
Lyle R. Heim United States
Pablo Cerezuela
Citations per year, relative to Pablo Cerezuela Pablo Cerezuela (= 1×) peers Xinghui Zhao

Countries citing papers authored by Pablo Cerezuela

Since Specialization
Citations

This map shows the geographic impact of Pablo Cerezuela's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Cerezuela with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Cerezuela more than expected).

Fields of papers citing papers by Pablo Cerezuela

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pablo Cerezuela. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Cerezuela. The network helps show where Pablo Cerezuela may publish in the future.

Co-authorship network of co-authors of Pablo Cerezuela

This figure shows the co-authorship network connecting the top 25 collaborators of Pablo Cerezuela. A scholar is included among the top collaborators of Pablo Cerezuela based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pablo Cerezuela. Pablo Cerezuela is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Muñoz-Prieto, Alberto, Edgar García Manzanilla, Pablo Cerezuela, et al.. (2025). Use of Saliva Analytes as a Predictive Model to Detect Diseases in the Pig: A Pilot Study. Metabolites. 15(2). 130–130.
3.
Martínez‐Subiela, Silvia, G. Ramis, Pablo Cerezuela, et al.. (2025). Serpin B12 in saliva of pigs: Development and analytical validation of an assay for its quantification and changes in sepsis and stress conditions. Research in Veterinary Science. 185. 105561–105561. 1 indexed citations
4.
González‐Cao, María, Teresa Puértolas, José Luís Zamora Manzano, et al.. (2024). Access to melanoma drugs in Spain: a cross-sectional survey. Clinical & Translational Oncology. 26(10). 2572–2583. 3 indexed citations
5.
Escribano, Damián, Pablo Cerezuela, Antonio Avellaneda, et al.. (2024). Comparison of the Effect of Two Different Handling Conditions at Slaughter in Saliva Analytes in Pigs. Metabolites. 14(4). 234–234. 4 indexed citations
6.
Escribano, Damián, Marina López-Arjona, Pablo Cerezuela, et al.. (2022). Changes in a Comprehensive Profile of Saliva Analytes in Fattening Pigs during a Complete Productive Cycle: A Longitudinal Study. Animals. 12(14). 1865–1865. 16 indexed citations
7.
Márquez‐Rodas, Iván, Miguel‐Ángel Berciano‐Guerrero, Ainara Soria, et al.. (2021). 1056P Survival of patients with advanced melanoma according to first-line treatment and key prognostic factors: Real-world data from GEM1801 study. Annals of Oncology. 32. S881–S882. 1 indexed citations
8.
Trujillo‐Santos, Javier, Mercedes Salgado, Ignacio Escobar, et al.. (2021). PO-90 Characterization of thrombosis risk in patients with cancer: preliminary results. Thrombosis Research. 200. S67–S67. 1 indexed citations
10.
Arance, Ana, J.J. Ríos-Martín, Javier Hernández‐Losa, et al.. (2020). Frequency and Clinicopathological Profile Associated with Braf Mutations in Patients with Advanced Melanoma in Spain. Translational Oncology. 13(6). 100750–100750. 5 indexed citations
11.
Ciruelos, Eva, Dolores Isla, Rafael López‐López, et al.. (2019). Patient preference for oral chemotherapy in the treatment of metastatic breast and lung cancer. European Journal of Cancer Care. 28(6). e13164–e13164. 19 indexed citations
12.
Piñero, Antonio, et al.. (2019). Mitotic rate as an important prognostic factor in cutaneous malignant melanoma. Clinical & Translational Oncology. 21(10). 1348–1356. 19 indexed citations
13.
Gutiérrez, A.M., A. Montes, Cándido Gutiérrez Panizo, Pablo Cerezuela, & Ernesto de la Cruz Sánchez. (2017). Gender influence on the salivary protein profile of finishing pigs. Journal of Proteomics. 178. 107–113. 12 indexed citations
14.
Gutiérrez, A.M., Ernesto de la Cruz Sánchez, A. Montes, et al.. (2017). Easy and non-invasive disease detection in pigs by adenosine deaminase activity determinations in saliva. PLoS ONE. 12(6). e0179299–e0179299. 18 indexed citations
15.
Arance, Ana, Alfonso Berrocal, José A. López-Martín, et al.. (2016). Safety of vemurafenib in patients with BRAF V600 mutated metastatic melanoma: the Spanish experience. Clinical & Translational Oncology. 18(11). 1147–1157. 17 indexed citations
16.
Piñero, Antonio, et al.. (2013). Prescripción conjunta de antidepresivos y tamoxifeno: una cuestión a tener en cuenta. Revista de Senología y Patología Mamaria. 26(4). 134–137.
17.
Espinosa, Enrique, Alfonso Berrocal, José A. López-Martín, et al.. (2012). Advances in cutaneous melanoma. Clinical & Translational Oncology. 14(5). 325–332. 7 indexed citations
18.
Cerezuela, Pablo, et al.. (2010). Phase II Trial of Oxaliplatin and Capecitabine After Progression to First-Line Chemotherapy in Androgen-Independent Prostate Cancer Patients. American Journal of Clinical Oncology. 34(2). 155–159. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026